C. Wamboga

Towards an arsenic-free oral treatment for human African trypanosomiasis due to Trypanosoma brucei rhodesiense a new tool for disease elimination

E. Baudin, OV Mordt, D. Alves, J. Seixas +5 more

2024Towards an arsenic-free oral treatment for human African trypanosomiasis due to Trypanosoma brucei rhodesiense a new tool for disease elimination1 citations Open access

Semantic Scholar

C. Wamboga

Most-cited papers

Enhanced passive screening and diagnosis for gambiense human African trypanosomiasis in north-western Uganda – Moving towards elimination

Trypa-NO! contributes to the elimination of gambiense human African trypanosomiasis by combining tsetse control with “screen, diagnose and treat” using innovative tools and strategies

A multicentre, randomised, non-inferiority clinical trial comparing a nifurtimox-eflornithine combination to standard eflornithine monotherapy for late stage Trypanosoma brucei gambiense human African trypanosomiasis in Uganda

Gambian human African trypanosomiasis in North West Uganda. Are we on course for the 2020 target?

Latent Trypanosoma brucei gambiense foci in Uganda: a silent epidemic in children and adults?

Estimating the impact of Tiny Targets in reducing the incidence of Gambian sleeping sickness in the North-west Uganda focus

Fexinidazole as a new oral treatment for human African trypanosomiasis due to Trypanosoma brucei rhodesiense: a prospective, open-label, single-arm, phase 2-3, non-randomised study.

Optimising passive surveillance of a neglected tropical disease in the era of elimination: A modelling study

Vector control and the elimination of gambiense human African trypanosomiasis (HAT) - Joint FAO/WHO Virtual Expert Meeting, 5-6 October 2021

A survey of livestock to identify the presence of human infective trypanosomes in the Trypanosoma brucei gambiense endemic districts of north-west Uganda

Towards an arsenic-free oral treatment for human African trypanosomiasis due to Trypanosoma brucei rhodesiense a new tool for disease elimination

Transmission and cost-effectiveness modelling to estimate the progress towards elimination and future strategy optimisation for gambiense human African trypanosomiasis in Uganda

National capacity strengthening within the context of an international vector control partnership: findings from a qualitative study conducted within the Ugandan ‘Tiny Targets’ programme

OA-504 Towards an arsenic-free oral treatment for human African trypanosomiasis due to Tb rhodesiense: a new tool for disease elimination

Trends and spatial distribution of Human African Trypanosomiasis (HAT), Uganda, 2005 – 2015: A descriptive analysis of surveillance data